MARKET WIREYahoo • 6d ago
Nasdaq-Listed Solana Company Gains Strategic Enterprise Status in Hong KongHong Kong has named Nasdaq-listed Solana Company (NASDAQ: $HSDT) a strategic enterprise under a government program ...
Why HSDT Stock slipped -1.31% Today — RQD Quant Desk Flash
$2.26 -1.31% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $2.25
Solana Company (Class A) (HSDT) carries a Roarable Rating of D- (Sell) with 37/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D- • RED ALERT
Cap $146.5M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on HSDT Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is HSDT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-01, Solana Company (Class A) (NASDAQ: HSDT) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 37/100 at a spot price of $2.26 (-1.31% 1D, market cap $146.5M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, HSDT ranks #754 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does HSDT compare to FOCL and VANI in the Health Care sector?
▼
Within the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus), HSDT carries a Roarable D- (37/100 RQD), trailing P/E of N/A, gross margin of 96.0%, and ROIC of -35.0%. By comparison, FOCL (EDAP TMS S.A.) holds a E grade (29/100 RQD, P/E N/A, ROIC -35.0%, cap $191.6M) and VANI (Vivani Medical Inc.) posts a E grade (34/100 RQD, P/E 3.9x, ROIC -35.0%, cap $102.8M). Among the 5-stock peer group, VANI leads on earnings multiple (3.9x) while ELMD leads on capital efficiency (24.1% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for HSDT?
▼
Per HSDT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001610853), Solana Company (Class A) generated $548.0K in revenue (+5.4% YoY), -$40.9M in net income, and -$16.5M in free cash flow against $303.9M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $2.25 (-0.43%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 9/20 (D) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (37/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-8.1% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • D-
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw E · Rk D-
Each axis scored 0–20
12M PRICE TARGET CONE-9.3% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for HSDT)Realized 20D OHLCV Swing Band: ±11.6%
Deterministic 5-Pillar Attribution (37/100 Composite)
🔍 WHY HSDT SCORES 37/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+11/20 pts (30% of score)
Altman Z-Score 25.63 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9
▲ #2 Bullish Driver: Cash Engine Quality+9/20 pts (24% of score)
SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 551.7% Gross Margin
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$2.39-6.3% Next Q
45
Q2 (-2Q)Grade D$2.24+0.9% Next Q
42
Q3 (-1Q)Grade D$2.26+0% Next Q
40
CurrentGrade D-$2.26-8.1% Hist 90D α
37
Trajectory: D (45) → D- (37)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a HSDT Turnaround Squeeze
While HSDT currently carries a cautious 37/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.41) and Max Pain ($2.37) forces dealer call-delta covering toward $6.29.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $HSDT• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “HSDT Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why HSDT Stock slipped -1.31% Today — RQD Quant Desk Flash
Solana Company (Class A) (HSDT) slipped -1.31% to $2.26, trading at 22% of its 52-week range ($1.19 – $5.99). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 22% of its 52-week range ($1.19 – $5.99) with RSI-14 at 37.4 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±11.6% around $2.26 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 551.7% gross margin and $0 annual free cash flow.
Live HSDT Headlines & Catalysts
MARKET WIREBenzinga • 10d ago
Solana Designated As Strategic Enterprise By Hong Kong SAR Government’s Office For Attracting Strategic EnterprisesSolana Company (NASDAQ:HSDT) (the "Company"), a publicly listed digital asset infrastructure and services company, today announced that it has been designated as a strategic enterprise by the Hong Kong SAR
MARKET WIRESeekingAlpha • 11d ago
SkyAI: The $3 Tender Offer Doesn't Solve The Valuation ProblemON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring HSDT)
- ✓Walkthrough of HSDT's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
HSDT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +10.78%▲ ASCENDING CHANNEL
2026-10-30O $2.15H $2.26L $2.04C $2.26VOL 562.0K
RES: $4.09SUP: $1.87SMA50: $2.41SMA200: $2.10
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
HSDT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +5.4% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on HSDT today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for HSDT. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for HSDT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (HSDT)
Health Care Rank #754 of 1016
⚔️ FOCL vs HSDT Full Matrix →
1. Head-to-Head Health Care Peer Comparison (HSDT vs. FOCL, VANI, NRXS, ELMD)
Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus (26 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Solana Company (Class A) (HSDT) ranks #754 by composite RQD confidence (37/100, grade D-) and #613 by equity capitalization ($146.5M). Within this direct 5-issuer industry benchmark cohort, VANI leads on earnings valuation at 3.9x trailing P/E, while ELMD leads on capital efficiency and profitability with 24.1% ROIC and 78.1% gross margin. ELMD currently holds the highest overall quantitative score in the immediate peer group at 77/100 (B+) compared with HSDT at 37/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| HSDT
ACTIVE
Solana Company (Class A) | D- | 37/100 | — | 96.0% | -35.0% | -1.31% | $146.5M | Benchmark Subject |
| FOCL EDAP TMS S.A. | E | 29/100 | — | 42.5% | -35.0% | -2.11% | $191.6M | /focl-vs-hsdt → |
| VANI Vivani Medical Inc. | E | 34/100 | 3.9x | — | -35.0% | 0.00% | $102.8M | /vani-vs-hsdt → |
| NRXS Neuraxis Inc. | E | 32/100 | — | 84.2% | -35.0% | -0.26% | $94.8M | /nrxs-vs-hsdt → |
| ELMD Electromed Inc. | B+ | 77/100 | 30.4x | 78.1% | 24.1% | +1.47% | $229.4M | /elmd-vs-hsdt → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001610853In its most recent audited fiscal period (FY2025, filed 2025-12-31), Solana Company (Class A) (HSDT) reported GAAP revenue of $548.0K (+5.4% vs. FY2024 revenue of $520.0K , and -9.4% cumulative change since FY2023) , GAAP net income of -$40.9M, operating cash flow of -$16.5M, and free cash flow of -$16.5M (-49.5% YoY). On the balance sheet, HSDT closed FY2025 with $303.9M in total assets against $0 in total debt (Altman Z-Score: 25.63, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $548.0K | -$40.9M | -$16.5M | -$16.5M | $303.9M | — |
| FY2024 (FY) | 2024-12-31 | $520.0K | -$11.7M | -$11.0M | -$11.0M | $3.5M | — |
| FY2023 (FY) | 2023-12-31 | $605.0K | -$8.9M | -$10.4M | -$10.4M | — | — |
3. HSDT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs HSDT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Solana Company (Class A) (NASDAQ: HSDT) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 37/100 at a spot price of $2.26 (-1.31% 1D, market cap $146.5M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, HSDT ranks #754 in composite RQD confidence.
How does HSDT compare to FOCL and VANI in the Health Care sector?
Within the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus), HSDT carries a Roarable D- (37/100 RQD), trailing P/E of N/A, gross margin of 96.0%, and ROIC of -35.0%. By comparison, FOCL (EDAP TMS S.A.) holds a E grade (29/100 RQD, P/E N/A, ROIC -35.0%, cap $191.6M) and VANI (Vivani Medical Inc.) posts a E grade (34/100 RQD, P/E 3.9x, ROIC -35.0%, cap $102.8M). Among the 5-stock peer group, VANI leads on earnings multiple (3.9x) while ELMD leads on capital efficiency (24.1% ROIC).
What are the biggest fundamental strengths and SEC risk factors for HSDT?
Per HSDT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001610853), Solana Company (Class A) generated $548.0K in revenue (+5.4% YoY), -$40.9M in net income, and -$16.5M in free cash flow against $303.9M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is HSDT trading relative to its 50-day, 200-day, and 52-week technical levels?
HSDT last traded at $2.26 (-1.31% on volume of 362,790 shares), positioning the stock -6.22% below its 50-day simple moving average ($2.41) and +7.62% above its 200-day simple moving average ($2.10). Across its 52-week range of $1.19 to $5.99, HSDT sits at the 22.3% percentile with a 14-day RSI of 37.4 (NEUTRAL RANGE) and an implied next-earnings move of ±11.6% ($2.00 to $2.52).
HSDT Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is HSDT stock moving today?
Why HSDT Stock slipped -1.31% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.